Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology Fourth Quarter Fiscal Year 2025 Earnings Call. [Operator Instructions] Please note this conference is being recorded.
Champions Oncology Inc. (CSBR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 181,039 | $1,334,257 | +20% | 0% |
| 2. | Millennium Management Israel Englander | 24,064 | $177,352 | -64% | 0% |
| 3. | 15,800 | $116,446 | +9% | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 1,000 | $6,500.00 | 198,625 | 2024-01-12 | Filing | |
| $6.27 | 2,000 | $12,540.00 | 197,625 | 2024-01-11 | Filing | |
| $6.31 | 2,944 | $18,576.64 | 195,625 | 2024-01-10 | Filing | |
| $6.25 | 3,000 | $18,750.00 | 192,681 | 2024-01-09 | Filing | |
| $6.15 | 1,000 | $6,150.00 | 189,681 | 2024-01-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.35 | 31,443 | $356,975.52 | 0 | 2020-12-16 | Filing | |
| $5.25 | 75 | $393.75 | 837,168 | 2020-03-24 | Filing | |
| $6.99 | 708,155 | $4,950,003.45 | 1,713,720 | 2020-03-06 | Filing | |
| $13.75 | 5,000 | $68,750.00 | 57,500 | 2018-11-06 | Filing | |
| $13.02 | 8,333 | $108,495.66 | 62,500 | 2018-09-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,421,673 | $17,847,730 | 3.14% | |
| 2. | 1,713,720 | $12,630,116 | 0.95% | |
| 3. | 399,882 | $2,947,130 | 0.04% | |
| 4. | 327,029 | $2,410,203 | 0% | |
| 5. | 130,500 | $961,785 | 0% |
News See All
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2025 Earnings Call [Operator Instructions]. Please note, this conference is being recorded.
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology First Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Champions Oncology's Fourth Quarter Fiscal Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2024 Earnings Call. At this time all participants are in a listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology Second Quarter Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Champions Oncology First Quarter Fiscal Year 2024 Earnings Call. At this time all participants are in a listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Champions Oncology's Fourth Quarter and Fiscal Year-End 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Champions Oncology Third Quarter Fiscal Year 2023 Earnings Call. It is now my pleasure to turn the floor over to your host, Dr.